A Study of Mosliciguat in PH-ILD
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ubaldo Martin, MD
Pulmovant, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arizona Pulmonary Specialists
Phoenix, Arizona, United States
- Ronald Reagan Ucla Medical Center
Los Angeles, California, United States
- University of California Davis School of Medicine
Sacramento, California, United States
- Harbor-Ucla Medical Center - Torrance
Torrance, California, United States
- Florida Lung, Asthma & Sleep Specialists/clinical Research Specialists, Llc
Celebration, Florida, United States
- Northwestern University
Chicago, Illinois, United States
- University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
- University of Kansas Medical Center
Kansas City, Kansas, United States
- Norton Pulmonary Specialists
Louisville, Kentucky, United States
- Duke University Health System - Duke Clinic
Durham, North Carolina, United States
- Pulmonix
Greensboro, North Carolina, United States
- Hoxworth Blood Center
Cincinnati, Ohio, United States
- Summit Health
Bend, Oregon, United States
- Lewis Katz School of Medicine
Philadelphia, Pennsylvania, United States
- Brown Medicine
East Providence, Rhode Island, United States
- Medical University of South Carolina
Charleston, South Carolina, United States
- Houston Methodist Lung Center
Houston, Texas, United States
- University of Utah Health
Salt Lake City, Utah, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Oct 2024
- Primary completion
- 31 Dec 2026
- Completion
- 31 Jan 2028
- Last update posted
- 20 Feb 2026
- Registered enrollment
- 135
- Registry id
- NCT06635850
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.